Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.
Inogès S, Rodrìguez-Calvillo M, Zabalegui N, Lòpez-Dìaz de Cerio A, Villanueva H, Soria E, Suárez L, Rodríguez-Caballero A, Pastor F, García-Muñóz R, Panizo C, Pèrez-Calvo J, Melero I, Rocha E, Orfao A, Bendandi M; Grupo Español de Linfomas/Trasplante Autologo de Medula Oseo study group; Programa para el Estudio y Tratamiento de Hemopatias Malignas study group. Inogès S, et al. Among authors: pastor f. J Natl Cancer Inst. 2006 Sep 20;98(18):1292-301. doi: 10.1093/jnci/djj358. J Natl Cancer Inst. 2006. PMID: 16985248 Clinical Trial.
An RNA toolbox for cancer immunotherapy.
Pastor F, Berraondo P, Etxeberria I, Frederick J, Sahin U, Gilboa E, Melero I. Pastor F, et al. Nat Rev Drug Discov. 2018 Oct;17(10):751-767. doi: 10.1038/nrd.2018.132. Epub 2018 Sep 7. Nat Rev Drug Discov. 2018. PMID: 30190565 Review.
CD28 aptamers as powerful immune response modulators.
Pastor F, Soldevilla MM, Villanueva H, Kolonias D, Inoges S, de Cerio AL, Kandzia R, Klimyuk V, Gleba Y, Gilboa E, Bendandi M. Pastor F, et al. Mol Ther Nucleic Acids. 2013 Jun 11;2(6):e98. doi: 10.1038/mtna.2013.26. Mol Ther Nucleic Acids. 2013. PMID: 23756353 Free PMC article.
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity.
Soldevilla MM, Villanueva H, Meraviglia-Crivelli D, Menon AP, Ruiz M, Cebollero J, Villalba M, Moreno B, Lozano T, Llopiz D, Pejenaute Á, Sarobe P, Pastor F. Soldevilla MM, et al. Among authors: pastor f. Mol Ther. 2019 Nov 6;27(11):1878-1891. doi: 10.1016/j.ymthe.2019.07.013. Epub 2019 Jul 25. Mol Ther. 2019. PMID: 31405808 Free PMC article.
Aptamers: A Feasible Technology in Cancer Immunotherapy.
Soldevilla MM, Villanueva H, Pastor F. Soldevilla MM, et al. Among authors: pastor f. J Immunol Res. 2016;2016:1083738. doi: 10.1155/2016/1083738. Epub 2016 Jun 20. J Immunol Res. 2016. PMID: 27413756 Free PMC article. Review.
314 results